Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study).
| Image |  |
|---|---|
| Description | scientific article published on 25 December 2016 |
| Author/s |
author: Dae Ryong Cha Ki Ryang Na |
| Publication date | February 17, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |